Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark (Q39882847)

15 September 2017

Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark (English)

1 reference

cost-effectiveness analysis

15 September 2017

1 reference

0 references

Jens Olsen

1

1 reference

15 September 2017

Martin Rudbeck Jepsen

series ordinal

2

1 reference

15 September 2017

language of work or name

1 reference

1 April 2010

1 reference

International Journal of Technology Assessment in Health Care

15 September 2017

1 reference

15 September 2017

26

1 reference

15 September 2017

183-191

1 reference

15 September 2017

2

1 reference

[Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France]

15 September 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0266462310000085

Economic evaluation of human papillomavirus vaccination in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462310000085

The economic burden of noncervical human papillomavirus disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462310000085

Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462310000085

The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462310000085

Model for assessing human papillomavirus vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462310000085

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462310000085

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462310000085

Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462310000085

Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462310000085

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462310000085

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462310000085

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462310000085

Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462310000085

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S0266462310000085

1 reference

release_ihqbg5gk25bh3bcikj7a2cjyja

15 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ihqbg5gk25bh3bcikj7a2cjyja

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference